Research Article

Retinoic Acid Restores Adult Hippocampal Neurogenesis and Reverses Spatial Memory Deficit in Vitamin A Deprived Rats

  • Emilie Bonnet equal contributor,

    equal contributor Contributed equally to this work with: Emilie Bonnet, Katia Touyarot

    Affiliations: Nutrition & Neurosciences laboratory, University of Bordeaux 1, Talence, France, University of Bordeaux 2, Bordeaux, France

  • Katia Touyarot equal contributor mail,

    equal contributor Contributed equally to this work with: Emilie Bonnet, Katia Touyarot

    Affiliations: Nutrition & Neurosciences laboratory, University of Bordeaux 1, Talence, France, University of Bordeaux 2, Bordeaux, France

  • Serge Alfos,

    Affiliations: Nutrition & Neurosciences laboratory, University of Bordeaux 1, Talence, France, University of Bordeaux 2, Bordeaux, France

  • Véronique Pallet,

    Affiliations: Nutrition & Neurosciences laboratory, University of Bordeaux 1, Talence, France, University of Bordeaux 2, Bordeaux, France

  • Paul Higueret,

    Affiliations: Nutrition & Neurosciences laboratory, University of Bordeaux 1, Talence, France, University of Bordeaux 2, Bordeaux, France

  • Djoher Nora Abrous

    Affiliations: University of Bordeaux 2, Bordeaux, France, Neurogenesis & Pathophysiology laboratory, Bordeaux Neuroscience Research Center, INSERM 862, Bordeaux, France

  • Published: October 22, 2008
  • DOI: 10.1371/journal.pone.0003487


A dysfunction of retinoid hippocampal signaling pathway has been involved in the appearance of affective and cognitive disorders. However, the underlying neurobiological mechanisms remain unknown. Hippocampal granule neurons are generated throughout life and are involved in emotion and memory. Here, we investigated the effects of vitamin A deficiency (VAD) on neurogenesis and memory and the ability of retinoic acid (RA) treatment to prevent VAD-induced impairments. Adult retinoid-deficient rats were generated by a vitamin A-free diet from weaning in order to allow a normal development. The effects of VAD and/or RA administration were examined on hippocampal neurogenesis, retinoid target genes such as neurotrophin receptors and spatial reference memory measured in the water maze. Long-term VAD decreased neurogenesis and led to memory deficits. More importantly, these effects were reversed by 4 weeks of RA treatment. These beneficial effects may be in part related to an up-regulation of retinoid-mediated molecular events, such as the expression of the neurotrophin receptor TrkA. We have demonstrated for the first time that the effect of vitamin A deficient diet on the level of hippoccampal neurogenesis is reversible and that RA treatment is important for the maintenance of the hippocampal plasticity and function.


Vitamin A deficiency (VAD), leading to retinoic acid (RA) hyposignaling, represents a major public health problem and is estimated to affect 200 million children and adults in many countries [1], [2]. A disruption of retinoid signaling pathway has been involved in the pathophysiology of affective disorders, schizophrenia and late-onset Alzeimer's disease [2][8]. Animals' studies have shown that vitamin A and RA play a key role during brain development [9][12], and during adulthood, retinoids have been shown to modulate emotional and memory functions [2], [13].

The effects of retinoids on memory have been proposed to be mediated, at least in part, by an alteration of hippocampal plasticity. Indeed, retinoids are required for long term synaptic plasticity in the hippocampal formation (HF) [14], [15], a key structure in memory processing [16], [17]. Furthermore, vitamin A deficiency impairs spatial memory [18], [19]. In aged subjects, the naturally occurring hypoactivity of the retinoid signaling pathway also induces spatial memory and hippocampal long term potentiation deficits, which are alleviated by the normalization of brain retinoid signaling with RA treatment or nutritional vitamin A supplementation [20], [21]. Despite these striking relationships between retinoid signaling and memory, the mechanisms by which hippocampal retinoid hyposignaling influence learning abilities remain largely unknown.

The dentate gyrus (DG) of the HF is one of the areas where neurons are generated throughout the lifespan [22][24]. The newly born cells express neuronal markers, emit axons, receive synaptic inputs; in addition, their electrophysiological properties are very similar to those of mature dentate granule neurons. Neurogenesis has been hypothesized to play an important role in spatial memory [23], [25], [26]. Recently, its specific contribution to spatial memory evaluated in the water maze has been evidenced using genetic approaches [27], [28]. The ability of RA to promote in vitro neurogenesis [29][31] suggested that activation of retinoid signaling constitutes a therapeutic strategy to increase adult hippocampal neurogenesis and consequently hippocampal-dependent memory [3], [32]. However, contrasting results have been obtained in vivo. Long term exposure to RA decreases hippocampal neurogenesis [33], whereas maternal VAD disrupts irreversibly adult hippocampal neurogenesis in the adult offspring [34]. Consequently, the influence of retinoid signaling on this novel form of structural plasticity still remains controversial.

Here, we tested the hypothesis that retinoid hyposignaling decreases adult hippocampal neurogenesis and spatial memory. In order to address this issue, retinoid-deficient rats have been generated by a vitamin A-free diet from weaning. This nutritional approach enables normal embryogenesis and postnatal development, does not altered mother-infant interaction while permitting controlled vitamin A depletion in the adult rat. We further examined whether these effects could be reversed by RA treatment in adulthood. Finally, we investigated possible retinoid target genes as neurotrophin receptors that could be involved in these processes.We have demonstrated that both hippocampal neurogenesis and spatial memory can be rescued by RA treatment in vitamin A deficient rats.

Materials and Methods


Weaning male Wistar rats (3-week old) were purchased from Harlan (Gannat, France). They were housed two per cage in a room with a constant airflow system, controlled temperature (21–23°C), and a 12 h light/dark cycle. The rats were given ad libitum access to food and water and were randomly divided into two experimental groups. One group (n = 55) received a vitamin A-free diet (Laboratorio Piccionni, Italy), whereas the second group (n = 52) was fed with a control diet containing 5 IU retinol/g (INRA, Jouy en Josas). All animals were individually housed from one week prior to the beginning of RA treatment until sacrifice. All experiments were performed in accordance with the European Communities Council Directives (86/609/EEC) and the French national Committee (87/848) recommendations.


RA injections.

Half the control and VAD rats were injected daily with RA (150 µg of all-trans-RA/kg, Sigma, France). RA was dissolved in a mixture (vehicle) containing polyethyleneglycol-NaCl-ethanol (70:20:10, by vol.). This dose of RA was shown to be effective in reversing age-related hypoexpression of brain signaling and its associated memory impairment [20]. The other half of the animals was treated daily with vehicle only.

5-Bromo-2′-deoxyuridine (BrdU) injections.

In order to label the newly born cells and examine hippocampal cell survival, BrdU, a thymidine analogue incorporated into genetic material during synthetic DNA phase of mitotic division, was used. Rats received a daily intraperitoneal injection of BrdU (50 mg/kg, Sigma, France), dissolved in phosphate buffer (0.1 M, pH 8.4), during the 4 consecutive days beginning 4 days after the first injection of RA.


Rats were anesthetized with pentobarbital (100 µl per 100 g) and perfused transcardially with 200 ml of phosphate-buffered saline (PBS, pH 7.4) containing heparin, followed by 300 ml of 4% paraformaldehyde. After 1 week postfixation period in paraformaldehyde, 50 µm frontal sections were cut on a vibratome (Leica). Free-floating sections were processed with a standard immunohistochemical procedure [35]. A one–in-ten section was treated for KI-67 immunoreactivity using a mouse anti-KI-67 monoclonal antibody (1:200, Novocastra, Newcastle, U.K.) or for double-cortin (DCX) immunoreactivity using a goat polyclonal antibody (1:1000, Santa Cruz Biotechnology, Santa Cruz, California). Secondary antibodies were biotinylated horse anti-mouse and donkey anti-goat (1:200, AbCys; 1:200, Amersham). For BrdU labeling, adjacent sections were treated with 2N HCl to denature DNA (30 min at 37°C) and then washed in phosphate buffer. Sections were incubated with a mouse monoclonal anti-BrdU antibody (1:200, Dako) followed by the biotinylated horse anti-mouse antibody (1:200, AbCys). Sections were processed in parallel, and immunoreactivities were visualized by the biotin-streptavidin technique (ABC kit, Dako) by using 3,3′-diaminobenzidine as chromogen.

The number of immunoreactive (IR) cells in the left DG was estimated by using a modified version of the optical fractionator method with a systematic random sampling of every 10 sections along the rostrocaudal axis of the DG. On each section, IR cells in the granular and subgranular layers of the DG were counted with a 100× microscope objective [35]. All results are expressed as the total number of cells in the whole DG.

To analyze the phenotype of BrdU labeled cells, 8 rats per group were randomly selected. One in ten sections obtained from the second experiment was incubated with rat anti-BrdU monoclonal antibodies (1:500, Servibio), which were revealed by using CY3-labeled anti-rat IgG antibodies (1:1000, Interchim). Sections were then incubated with mouse monoclonal anti-NeuN antibodies (1:1000, Euromedex), and bound anti-NeuN monoclonal antibodies were visualized with an Alexa 488 goat anti-rabbit IgG (1:1000, Interchim). The percentage of BrdU-labeled cells that expressed NeuN was determined throughout the DG by using a confocal microscope with HeNe and Argon lasers (Nikon PCM 2000). All BrdU double labeled cells were examined, and sections were optically sliced in the Z plane by using a 1 µm interval. Cells were rotated in orthogonal planes to verify double labeling.

Behavioral testing

Rats were tested in a Morris water maze (180 cm diameter, 60 cm high) filled with water (22°C) made opaque by addition of white paint. An escape platform was hidden 2 cm below the surface of the water in a fixed location in one of four quadrants halfway between the wall and the middle of the pool. Before the start of the training, animals were habituated to the pool without a platform for 1 min/day for 2 days. During training, animals were required to locate the submerged platform by using distal extramaze cues. They were tested for four trials per day (90 s with an intertrial interval of 60 s, beginning from three different start points randomized every day) for 7 consecutive days. The distance covered to find the platform and the time to reach the platform were measured with a computerized tracking system (Videotrack, Viewpoint, Lyon, France). After the last training day, on day 8, animals were placed for 60 s in the pool without the platform (probe test). Performance was evaluated by the percentage of time spent in the quadrant where platform was located during training (target quadrant). Finally, in order to control for visual acuity deficits, the hidden platform was replaced by a visible platform located in the opposite quadrant, and animals were tested for four trials (90 s) over one day. One control rat treated with vehicle was excluded from the experiment due to failure to search for the platform during the acquisition phase (tigmotaxis).

Real-Time PCR analysis of neurotrophin receptor expression

Rats were sacrificed by decapitation, and each hippocampus was rapidly removed and stored at −80°C in order to measure neurotrophin receptor expression. Extraction of RNA was conducted using an extraction kit (TRIzol reagent, Invitrogen, France) according to the manufacturer's instructions. The quality and the concentration of RNA were determined by spectrophotometry. Then, the integrity of the purified RNA was verified using the RNA 6000 Pico LabChip kit in combination with the 2100 bioanalyser (Agilent Technologies). Using OligodT and random primers (Promega, France), cDNA was synthesized with ImPromII reverse transcriptase (Promega, France). Briefly, 1 µg of total RNA mixed with RNasin (Promega, France) and DNase (Roche, France) was incubated at 37°C. Then, OligodT plus random primers were added for incubation at 70°C. The reverse transcriptase reaction was performed at 42°C for 60 min in a final volume of 20 µl. The polymerase chain reaction (PCR) was performed in a LightCycler system (Roche Diagnostics, Germany). The forward and reverse primer sequences for each gene are in Table 1. To detect target genes amplification products, a LightCycler DNA Master SYBR Green I kit was used according to the manufacturer's instructions. PCR was performed in micro-capillary tubes in a final volume of 20 µl, containing 1× LC-DNA Master Green I mix, 4 mM MgCl2, 0.5 µM of each primer and 4 µl cDNA. The specificity and the identity of the amplified products was verified as follows: (1) melting curve analysis showed a single melting peak after amplification, and (2) amplified products for each gene were verified by sequencing with the Big Dye Terminator v1.1. (Applied Biosystems) and analyzed on a ABI 3130 sequencer (Applied Biosystems).


Table 1. Primers used for Light Cycler RT-PCR.


Quantification data were analyzed using the LightCycler Relative Quantification Software (Roche, Germany). Due to the fact that target and reference genes have different sequences and amplicon lengths, different PCR efficiencies could be found. For this reason, the software provides a calibrator-normalized relative quantification including a PCR efficiency correction [36]. In our case, the calibrator was chosen among the control rats. Results are expressed as the target/reference ratio divided by the target/reference ratio of the calibrator. Two housekeeping genes, PPIB and BMG, were used to quantify the expression of each gene (i.e TrkA, TrkB) in order to avoid possible errors related to our practice of using only one reference gene for normalization [37]. Thus, the expression of these housekeeping genes, which is the same in all groups of animals, has been shown to be unaffected by our experimental conditions. The results presented are normalized in comparison to PPIB.

Measurement of serum retinol concentration

Blood was collected and spun at 3000 rpm for 15 minutes. The supernatant was removed and snap frozen on dry ice. Serum retinol was assayed by HPLC according to a previously described method [38].

Experimental design

First experiment: effects of 11 weeks of VAD and one week RA treatment (between the 10th and 11th week of VAD) on neurogenesis.

We examined the effects of 11 weeks of a vitamin A-free diet on cell proliferation and neurogenesis in the DG. In order to study the role of RA, control and VAD rats were injected with RA or vehicle daily for one week during the 10th week of VAD. All groups (Control+vehicle, n = 8; Control+RA, n = 8; VAD+vehicle, n = 8; VAD+RA n = 9) were sacrificed at the 11th week of VAD (Fig. 1A). Cell proliferation was examined using an endogenous marker of the cell cycle, KI-67. DCX was used as a surrogate of neurogenesis.


Figure 1. Experimental protocols.

Weaning rats (3 weeks old) were submitted to 11 weeks or 14 weeks of vitamin A deficiency (VAD). The first two experiments were intended to study the effects of VAD and/or RA administration on hippocampal neurogenesis. The third experiment was designed to study the effects of VAD and/or RA administration on spatial memory and hippocampal neurotrophic receptor expression. The arrows and the grey bars indicate VAD and RA treatment, respectively.

Second experiment: effects of 14 weeks of VAD and four weeks RA treatment (between the 10th and 14th week of VAD) on cell survival and differentiation.

In a subsequent experiment, we examined the effects of VAD and RA treatment on cell survival and differentiation. From the 10th week of VAD, animals were injected with RA or vehicle daily for four weeks (Control+vehicle, n = 9; Control+RA, n = 8; VAD+vehicle, n = 9; VAD+RA n = 9). Four days after the beginning of RA treatment, all groups were injected with BrdU for 4 days. Rats were allowed to survive for another three weeks after the last injection of BrdU and continued treatment in their respective experimental conditions (Fig. 1B). In order to obtain more information about adult neurogenesis independent of BrdU, we studied the expression of DCX. Cell proliferation was also studied using the endogenous marker, KI-67.

Third experiment: effects of 14 weeks of VAD and four weeks RA treatment (between the 10th and 14th week of VAD) on spatial learning and memory and hippocampal neurotrophin receptor expression.

We then examined the influence of VAD and RA treatment on spatial memory. From the 10th week of VAD, animals were injected with RA or vehicle (Control+vehicle, n = 9; Control+RA, n = 10; VAD+vehicle, n = 10; VAD+RA, n = 10). Two weeks later, animals were tested in a watermaze task. All groups were sacrificed one week after the completion of behavioral testing to analyze neurotrophin receptor expression (Fig. 1C).

Statistical analysis

All results were expressed as mean±SEM. Data were submitted to analyses of variance. When appropriate, post-hoc comparisons were performed using the Fisher PLSD test. Whenever two groups were compared, an unpaired t-test was used.


Status of vitamin A deficiency

Analysis of serum retinol levels was performed after 11 or 14 weeks of VAD in order to confirm the status of VAD rats. Serum retinol concentration was significantly diminished by 11 weeks of VAD [Control:1.08±0.07 µmol/l; VAD:0.07±0.006 µmol/l, t(14) = −10.45, p<0.0001]. However, a whole vitamin A depletion was produced by 14 weeks of VAD, retinol being undetectable in the VAD serum at that time [Control:1.46±0.08 µmol/l; VAD:<0.01 µmol/l].

Effects of vitamin A deficiency and RA treatment on hippocampal neurogenesis

The influence of VAD and RA treatment were examined on hippocampal cell proliferation and neurogenesis (experiment 1). Cell proliferation was measured following 11 weeks of VAD, using an endogenous marker of cell cycle, KI-67 [39]. KI-67-labeled cells were located within the subgranular zone and were isolated or grouped in clusters (Fig. 2A). Quantitative analysis revealed that neither a control diet with or without RA injections, nor a VAD diet alone had an effect on cell proliferation (Fig. 3A). In contrast, the number of KI-67 expressing cells was increased by ~35% in VAD rats receiving RA injections for one week [F(3,29) = 3.66,p<0.05;C = C+RA = VAD<VAD+RA at least p<0.05]. We also determined whether 11 weeks of VAD and 1 week of RA treatment influence neurogenesis by using double-cortin (DCX), a microtubule-associated phosphoprotein, as a surrogate [40]. DCX-IR cells were located in the deepest region of granule cell layer (gcl) at the interface of the hilus. Their dendrites radiated into the molecular layer (Fig. 2B). A quantitative analysis revealed that 11 weeks of VAD or RA treatment has no effect on the number of newly generated neurons [Fig. 3B, F(3,29) = 1.51,p = 0.23].


Figure 2. Illustration of neurogenesis in the dentate gyrus.

Examples of : (A) Ki67-IR cells (B) DCX-IR cells and (C) 3-week-old BrdU-IR cells. (D) Three dimensional reconstruction of a z series along the y-z axis (narrow right panel) and x-z axis (narrow bottom panel) showing that a 3-week-old newly born cell (red) is double stained with the neuronal marker NeuN (green). Scale bar : A–C, 50 µm. gcl = granule cell layer.


Figure 3. Effects of 11 weeks of vitamin A deficiency and RA treatment on hippocampal neurogenesis.

Total number of: (A) KI-67-IR cells and (B) DCX-IR cells in the DG after 11 weeks of VAD. VAD for 11 weeks does not affect cell proliferation or the number of immature DCX neurons.*p<0.05, **p<0.01 when compared to VAD+RA.


The aim of the second study was twofold: (1) to determine whether cell proliferation and neurogenesis were influenced by a longer vitamin A deficient diet and RA treatment, and (2) to determine whether the survival and differentiation of cells born during the 10th week of VAD were influenced by subsequent VAD and/or RA treatment. To address this issue, animals were injected with BrdU 10 weeks after the beginning of VAD and allowed to survive for 3 additional weeks.

As expected, after 14 weeks, VAD decreased cell proliferation by ~32%. This effect was completely overcompensated by RA treatment, which by itself did not have any effect in control animals [Fig. 4A, F(3,31) = 11.95,p<0.0001 with VAD<C = C+RA<VAD+RA at least p<0.05]. We also found that the number of DCX expressing cells was decreased in VAD rats by ~25%, and this effect was overcompensated by RA administration [Fig. 4B; F(3,31) = 11.40,p<0.0001 with VAD<C = C+RA<VAD+RA at least p<0.05].


Figure 4. Effects of 14 weeks of vitamin A deficiency and RA treatment on hippocampal neurogenesis.

Total number of : (A) KI-67-IR cells, (B) DCX-IR cells, (C) 3 weeks old BrdU-IR cells and D) the extrapolated number of newly born neurons after 14 weeks of VAD. VAD for 14 weeks decreases cell proliferation and neurogenesis, an effect reversed by 4 weeks RA treatment.*p<0.05; ***p<0.001 when compared to VAD+RA, °°p<0.01 when compared to C.


When examining the effect of VAD and/or RA on cell survival, we found that most of the 3-week-old surviving BrdU-IR cells were isolated, round, large and located within the gcl (Fig. 2C). As shown in Fig. 4C, the number of BrdU-IR cells was not affected by a control diet with or without RA injections nor a VAD diet alone. In contrast, the number of BrdU labeled cells in VAD rats injected with RA was greater than that measured in the other groups [F(3,31) = 3.46,p<0.05 with C = VAD = C+RA<VAD+RA at least p<0.05].

The phenotype of newly born cells labeled with BrdU was determined using NeuN, a neuronal marker. The percentage of BrdU/NeuN double stained cells located in the gcl (Fig. 2D) did not differ between the four experimental groups [C:92.9±1.4, C+RA:91.4±1.4, VAD:89.8±2.3, VAD+RA:94.5±1.8; F(3,28) = 1.23,p = 0.31]. The ratio of BrdU-IR cells colabeled with NeuN was multiplied by the total number of BrdU-labeled cells to give an estimate of the total number of BrdU-labeled neurons. The extrapolated total number of 3-week-old, BrdU-labeled neurons in VAD rats receiving RA injections was higher than that of the other groups [Fig. 4D, F(3,28) = 5.162,p<0.01; with C = VAD = C+RA<VAD+RA at least p<0.05]. We then calculated the rate of cell survival by comparing, within each animal, the number of 3-week-old BrdU-IR cells to the number of proliferation KI67 cells. We found that this ratio was similar among the different groups [C:0.57±0.07, C+RA:0.75±0.10, VAD:0.72±0.10, VAD+RA:0.73±0.11, F(3,31) = 0.64, p = 0.59].

Thus, altogether these results showed that VAD decreases cell proliferation and neurogenesis; these effects are reversed by 4 weeks RA treatment. In contrast, cell survival and cell differentiation are not influenced by VAD and/or RA treatment.

Effects of vitamin A deficiency and RA treatment on spatial learning and memory

The previous experiments suggested that neurogenesis, as evaluated with DCX, was impaired after 11 weeks of VAD. Indeed, immature neurons expressed DCX until they are 2–3 weeks old [40], [41]. The 3 weeks delay necessary to observe a decrease in DCX expression indicates that reduction in cell proliferation occurred between the 11th and the 12th week of the VAD. For this reason, animals were trained in the water maze between the 12th and 13th week (Fig. 1C). In the water maze, animals are required to locate a hidden platform using the spatial cues available in the testing room. Control animals and animals treated with RA learned this task as shown by the progressive decrease in the distance covered to reach the hidden platform over the seven days of training (Fig. 5A). Memory impairment was observed in VAD rats that traveled a higher distance to find the platform. This deficit was reversed in VAD rats receiving RA treatment, with performance being similar to that observed in control rats [F(3,35) = 4.075,p<0.05 with VAD>C = C+RA = VAD+RA at least p<0.05]. Similar results were obtained for the latency to find the hidden platform [Fig. 5B, F(3,35) = 3.12,p<0.05 with VAD>C = C+RA = VAD+RA at least p<0.05]. VAD rats exhibited normal motor functioning, as evidenced by the lack of a significant difference in swimming speed [data not shown, F(3,35) = 1.32,p = 0.28].


Figure 5. Effects of 14 weeks of vitamin A deficiency and RA treatment on spatial memory in the water maze.

Spatial learning as shown by the evolution of the mean distance (A) covered by rats or the latency (B) to find the hidden platform. In the insert are shown the mean distance or the mean latency over the seven days of training. (C) Percentage of time spent by rats in the target quadrant; the dotted line corresponds to chance level. VAD-induced spatial memory deficits are rescued by RA treatment. ##p<0.01, ###p<0.001 when compared to C+RA, °p<0.05, °°°p<0.001 when compared to controls, *p<0.05, ***p<0.001 when compared to VAD+RA.


On day 8, memory for the platform location was tested using a probe test. The time spent in the quadrant previously containing the platform was measured. VAD rats failed to display a memory for the platform location, as indicated by a percent time swimming in the target quadrant around the chance level (25%, Fig. 5C). This deficit was reversed by RA administration [F(3,35) = 8.076,p<0.001; with VAD<C = C+RA = VAD+RA at least p<0.01]. After the probe trial on day 9, animals were trained to find a visible platform. The distance traveled [F(3,35) = 3.35,p = 0.093] and the latency [F(3,35) = 1.85,p = 0.15] to find a visible platform were identical for the different groups. These results indicate that learning differences were not due to differences in motor or visual capabilities, thigmotaxic behavior, or more generally to differences in health status.

Taken together, these results showed that VAD induced spatial memory deficits in the water maze that could be reversed by RA administration.

Effects of vitamin A deficiency and RA treatment on hippocampal neurotrophin receptor expression

The ability of RA to promote neurogenesis and improve memory abilities in VAD rats could be in part mediated by activation of neurogenesis-related gene expression via neurotrophin receptors, which are known to be regulated by RA in vitro [30], [42][46]. To uncover the possible mechanisms involved in the effect of VAD and RA treatment on neurogenesis, animals were sacrificed one week after the behavioral experiment (Fig. 1c). As seen in Fig. 6A, quantitative analysis of hippocampal TrkA mRNA expression indicated differences between groups [F(3,34) = 3.07,p<0.05]. Indeed, we observed that VAD tended to reduce hippocampal TrkA mRNA expression compared to control rats (36%, p = 0.09), which is fully upregulated by RA treatment (VAD<VAD+RA, p = 0.01). In contrast, RA administration in control rats had no effect on TrkA mRNA expression. When considering hippocampal levels of TrkB mRNAs, no significant variation was observed between groups [Fig. 6B, F(3,34) = 0.98, p = 0.41].


Figure 6. Effects of 14 weeks of vitamin A deficiency and RA treatment on mRNA expression of neurotrophic receptors in the hippocampus.

(A) TrkA and (B) TrkB mRNA expression as quantified by Real Time-PCR. RA treatment compensated VAD-induced reduction in hippocampal TrkA mRNA.**p<0.01 when compared to VAD+RA.


These data suggested that RA signaling may regulate TrkA transcription in the hippocampus that could be an important regulatory mechanism involved in the restoration of adult neurogenesis and spatial memory in VAD rats.


The results of the present experiments show that 14 weeks of VAD decreases hippocampal neurogenesis, based on the numbers of doublecortin-IR cells, and impairs spatial memory. These effects are reversed by 4 weeks RA treatment. Furthermore, the restoration of neurogenesis in VAD rats receiving RA treatment may in part be related to up-regulation of retinoid-mediated molecular events, such as the expression of the neurotrophin receptor TrkA.

We have shown that a VAD starting at weaning for 11 weeks did not affect cell proliferation or the number of immature DCX neurons when compared to control animals fed with a control diet containing 5 IU retinol/g. Although serum retinol concentration, a good indicator of vitamin A depletion, was significantly reduced, 11 weeks of diet was not sufficient to entirely deplete vitamin A reservoir. This may explain the lack of effects on neurogenesis. This result is in line with a previous study failing to observe a down-regulation of RA-regulated genes within the hippocampus after a short-term VAD (10 weeks). That treatment, however, was sufficient to decrease target gene expression in the striatum [47]. In contrast, a total depletion in serum retinol levels was observed after 14 weeks of VAD (undetectable levels). In this condition, we observed a decrease in cell proliferation and neurogenesis, as indicated by changes in KI-67 and DCX. This cytoplasmic protein is expressed by immature neurons until they are 2–3 weeks old [40], [41]. This developmental time course, together with the 3 weeks delay necessary to observe a decrease in DCX expression, suggests that the loss in immature neurons results from an initial reduction in cell proliferation occurring after the 11th week of the VAD. Furthermore, VAD did not seem to influence cell survival and differentiation. Indeed, the survival of the cells born during the 10th week of the VAD was not impaired by additional 4 weeks of VAD, and the rate of survival calculated in the same animals was not influenced by VAD. These results contrast with those obtained recently, which show that VAD administration from birth to 18 weeks of age failed to influence cell proliferation while decreasing the survival and neuronal differentiation of 3-week-old newly born cells [34]. The discrepancy between the two studies may be related to differences in the animal models. Indeed, in our study VAD was begun at weaning sparing the early postnatal period whereas in the other study VAD was began from birth. Differences in the duration of the vitamin A deficient diet, and/or the time and method of RA supplementation could also be involved.

Administration of RA (all-trans) to control rats for one or four weeks did not modify neurogenesis. This contrasts with a previous study showing that 13–cis-RA (anti-acne drug accutane) decreases hippocampal neurogenesis in mice after 3 weeks of treatment [33]. Species differences in RA sensitivity and/or differences in the dose of RA (150 µg vs 1 mg/kg/day) may explain the discrepancy between these studies. Furthermore, because 13-cis RA has a low affinity for RA receptors [48], the biological effects of these two retinoic acid isomers may also differ.

More importantly, we found that RA was very potent in animals with a RA hypo-signaling. First, it increased cell proliferation in rats submitted to 11 weeks of VAD. Second, the supernumerary cells generated in animals submitted to 11 weeks of VAD survived and differentiated into neurons. Third, 4 weeks RA treatment to 14-week-old VAD rats increased cell proliferation and neurogenesis (i.e. number of DCX neurons and number of BrdU-NeuN co-labeled neurons) above the control values. This overcompensation might be related to a hypersensitivity of the molecular cascade downstream the RA receptors (see below). In line with these results, neonatal administration of an inhibitor of RA synthesis (disulfiram) decreased cell proliferation in the subventricular zone (SVZ), another neurogenic zone [31].

RA may regulate neurogenesis via several mechanisms. RA might directly regulate neurogenesis by acting through its specific nuclear receptors, the nuclear retinoic acid receptors (RARα,β,γ) and the retinoid X receptors (RXRα,β,γ) [49][51], which are expressed by immature dividing cells. In the adult SVZ, a population of slowly dividing cells, the stem cells, has been shown to be activated by RA [52]. Consistent with that finding, SVZ–derived neurospheres expressing RARα,β,γ receptors also depend on RA signaling [52]. Thus, RA might increase hippocampal neurogenesis by activating the proliferation of stem cells present in this area. Moreover, RA has been shown to regulate neurogenesis in vitro by activating neurogenesis-related gene expression, including neurotrophin receptors [30]. Thus, the effects of VAD and RA were examined on TrkA, a receptor for Nerve Growth Factor (NGF) [42], [45], [46], and TrkB, a receptor for Brain Derived Neurotrophic Factor [43], [44] known to be expressed in the HF [53], [54]. Our results showed that VAD tended to reduce hippocampal TrkA expression (difference that was statistically significant when comparing TrkA expression between control and VAD groups using a t Test, p = 0.028). This effect was reversed by RA administration. In contrast, TrkB was not modified by VAD or RA. This finding suggested that RA, acting by increasing hippocampal expression of TrkA receptors, can potentiate NGF/TrkA signaling. This signaling may sustain the RA-induced increase in neurogenesis in VAD rats. Another non-exclusive possibility involves an indirect action via the septo-hippocampal cholinergic pathway. VAD reduces the activity of this pathway [18], [55], known to be under the control of NGF [56], [57]. Furthermore, immunolesion of this pathway decreases hippocampal neurogenesis [58], [59], whereas chronic treatment with NGF increases hippocampal neurogenesis [60]. Thus, it is possible that VAD impairs neurogenesis via a downregulation of the septo-hippocampal cholinergic pathway and that RA restores neurogenesis via an increased activity of these neurons.

Our results also demonstrated that VAD induced deficits in spatial memory in the water maze. Memory deficits evidenced in VAD rats did not result from visual alterations or motor impairments, known to appear following long-term diet [61][63] as they were able to find a visible platform. Furthermore, VAD rats were able to swim at similar speeds as control rats. The decline in spatial memory in VAD rats was fully restored by the RA administration, suggesting that activation of retinoid signaling through RA nuclear receptors is sufficient to alleviate the symptoms. Previous studies have shown that VAD [18], [19] or age-related brain retinoid hyposignaling [20] impairs spatial memory. More controversial are the effects of RA that can alleviate in some cases [18], [20] but not in all [19] retinoid hyposignaling-induced memory deficits. Furthermore, chronic 13-cis RA treatment of rats given a normal diet has been shown to either induce spatial memory deficits [33] or to produce no effect [64]. This discrepancy may be related to differences in subject age, species, and treatment used. In one study, spatial learning was impaired following a chronic RA treatment [33], a deficit probably due to the non-physiological dose of RA used (1 mg/kg).

Altogether, the present results suggest that spatial memory deficits observed after a hypoactivity of retinoid signaling could be in part related to an alteration of hippocampal neurogenesis. This contention is supported by the fact that RA treatment in VAD rats restores both hippocampal neurogenesis and hippocampal-dependent memory. Our VAD rats were profoundly impaired in the acquisition of spatial memory and exhibited the same learning curve as transgenic mice with ablation of adult-born hippocampal neurons [65]. However, future studies are needed to confirm a causal relationship between VAD-induced changes in neurogenesis and spatial memory. Our results also show that RA regulates neurogenesis and memory function by activating the transcription of TrkA receptors. However, we cannot exclude the possibility that a change in retinoid signaling influences neurogenesis and memory through a modification of synaptic plasticity. Indeed, VAD results in a reversible loss of hippocampal CA1 long term potentiation (LTP) and long term depression (LTD) [15]. Furthermore, age-related hypoactivity of retinoid signaling pathway impairs CA1 LTP, an effect abrogated by the normalization of retinoid signaling [20]. Thus, VAD-induced changes in synaptic plasticity within the DG could alter neurogenesis and spatial memory. This hypothesis is supported by the observation that hippocampal neurogenesis is increased by LTP [66]. However, controversial results have been obtained on the link between neurogenesis and LTP [67], [68] indicating that we cannot exclude that RA signaling affects hippocampal functions and neurogenesis through other mechanisms. Interestingly, memory dysfunction in aged rats, associated with hippocampal retinoid hyposignaling, is alleviated by RA-induced normalization of this retinoid signaling pathway [20]. Given that memory abilities have been related to hippocampal neurogenesis in aged rats [69], [70], this raises the issue as to whether RA-induced improvement in memory function in aged subjects depend upon an enhancement of neurogenesis.

Taken together, these data highlight the role of RA signaling in hippocampal plasticity and function. This is the first study showing that RA treatment, can counteract the effects of vitamin A deficiency on adult hippocampal neurogenesis disruption, one of the plasticity mechanisms involved in hippocampal-dependent spatial memory. Given the likely effects of RA treatment on hippocampus plasticity and function, a number of important future approaches arise from these results. In particular, the involvement of retinoids as a valuable strategy for the treatment of hippocampal-dependent disorders by promoting hippocampal plasticity and neurogenesis should be investigated.


The authors are grateful to L.Caune for animal care.

Author Contributions

Conceived and designed the experiments: EB KT SA VP PH DNA. Performed the experiments: EB KT. Analyzed the data: EB KT DNA. Contributed reagents/materials/analysis tools: EB KT SA VP PH DNA. Wrote the paper: EB KT SA DNA.


  1. 1. Sommer A (1995) Vitamin A deficiency and its consequences: a field guide to their detection and control. World Health Organization.
  2. 2. Bremner JD, McCaffery P (2008) The neurobiology of retinoic acid in affective disorders. Prog Neuropsychopharmacol Biol Psychiatry 32(2): 315–331.
  3. 3. Goodman AB (2006) Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease. J Cell Physiol 209(3): 598–603.
  4. 4. Corcoran JP, So PL, Maden M (2004) Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain. Eur J Neurosci 20(4): 896–902.
  5. 5. Goodman AB (1998) Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci U S A 95(13): 7240–7244.
  6. 6. Goodman AB, Pardee AB (2003) Evidence for defective retinoid transport and function in late onset Alzheimer's disease. Proc Natl Acad Sci U S A 100(5): 2901–2905.
  7. 7. Palha JA, Goodman AB (2006) Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia. Brain Res Rev 51(1): 61–71.
  8. 8. Husson M, Enderlin V, Delacourte A, Ghenimi N, Alfos S, et al. (2006) Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in beta-amyloid deposits in the cerebral cortex of vitamin A deprived rats. Neurobiol Dis 23(1): 1–10.
  9. 9. Chambon P (1996) A decade of molecular biology of retinoic acid receptors. Faseb J 10(9): 940–954.
  10. 10. McCaffery P, Drager UC (2000) Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor. Cytokine Growth Factor Rev 11(3): 233–249.
  11. 11. McCaffery PJ, Adams J, Maden M, Rosa-Molinar E (2003) Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci 18(3): 457–472.
  12. 12. Maden M (2007) Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 8(10): 755–765.
  13. 13. Lane MA, Bailey SJ (2005) Role of retinoid signalling in the adult brain. Prog Neurobiol 75(4): 275–293.
  14. 14. Chiang MY, Misner D, Kempermann G, Schikorski T, Giguere V, et al. (1998) An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression. Neuron 21(6): 1353–1361.
  15. 15. Misner DL, Jacobs S, Shimizu Y, de Urquiza AM, Solomin L, et al. (2001) Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity. Proc Natl Acad Sci U S A 98(20): 11714–11719.
  16. 16. O'Keefe J, Nadel L (1978) The hippocampus as a cognitive map. The Behavioral and Brain Sciences 2: 487–533.
  17. 17. Eichenbaum H (1999) The hippocampus and mechanisms of declarative memory. Behav Brain Res 103(2): 123–133.
  18. 18. Cocco S, Diaz G, Stancampiano R, Diana A, Carta M, et al. (2002) Vitamin A deficiency produces spatial learning and memory impairment in rats. Neuroscience 115(2): 475–482.
  19. 19. Etchamendy N, Enderlin V, Marighetto A, Pallet V, Higueret P, et al. (2003) Vitamin A deficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signalling. Behav Brain Res 145(1–2): 37–49.
  20. 20. Etchamendy N, Enderlin V, Marighetto A, Vouimba RM, Pallet V, et al. (2001) Alleviation of a selective age-related relational memory deficit in mice by pharmacologically induced normalization of brain retinoid signaling. J Neurosci 21(16): 6423–6429.
  21. 21. Mingaud F, Mormede C, Etchamendy N, Mons N, Niedergang B, et al. (2008) Retinoid hyposignaling contributes to aging-related decline in hippocampal function in short-term/working memory organization and long-term declarative memory encoding in mice. J Neurosci 28(1): 279–291.
  22. 22. Gross CG (2000) Neurogenesis in the adult brain: death of a dogma. Nat Rev Neurosci 1(1): 67–73.
  23. 23. Abrous DN, Koehl M, Le Moal M (2005) Adult neurogenesis: from precursors to network and physiology. Physiol Rev 85(2): 523–569.
  24. 24. Piatti VC, Esposito MS, Schinder AF (2006) The timing of neuronal development in adult hippocampal neurogenesis. Neuroscientist 12(6): 463–468.
  25. 25. Leuner B, Gould E, Shors TJ (2006) Is there a link between adult neurogenesis and learning? Hippocampus 16(3): 216–224.
  26. 26. Abrous DN, Wojtowicz JM (2008) Neurogenesis and hippocampal memory system in adult neurogenesis. New York 445–461.
  27. 27. Dupret D, Revest J, Koehl M, Ichas F, De Giorgi F, et al. (2008) Spatial relational memory requires hippocampal adult neurogenesis? PLosOne in press.
  28. 28. Zhang CL, Zou Y, He W, Gage FH, Evans RM (2008) A role for adult TLX-positive neural stem cells in learning and behaviour. Nature 451(7181): 1004–1007.
  29. 29. Wu G, Fang Y, Lu ZH, Ledeen RW (1998) Induction of axon-like and dendrite-like processes in neuroblastoma cells. J Neurocytol 27(1): 1–14.
  30. 30. Takahashi J, Palmer TD, Gage FH (1999) Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures. J Neurobiol 38(1): 65–81.
  31. 31. Wang TW, Zhang H, Parent JM (2005) Retinoic acid regulates postnatal neurogenesis in the murine subventricular zone-olfactory bulb pathway. Development 132(12): 2721–2732.
  32. 32. Mey J (2006) New therapeutic target for CNS injury? The role of retinoic acid signaling after nerve lesions. J Neurobiol 66(7): 757–779.
  33. 33. Crandall J, Sakai Y, Zhang J, Koul O, Mineur Y, et al. (2004) 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci U S A 101(14): 5111–5116.
  34. 34. Jacobs S, Lie DC, Decicco KL, Shi Y, Deluca LM, et al. (2006) Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc Natl Acad Sci U S A 103(10): 3902–3907.
  35. 35. Lemaire V, Lamarque S, Le Moal M, Piazza PV, Abrous DN (2006) Postnatal stimulation of the pups counteracts prenatal stress-induced deficits in hippocampal neurogenesis. Biol Psychiatry 59(9): 786–792.
  36. 36. Feart C, Mingaud F, Enderlin V, Husson M, Alfos S, et al. (2005) Differential effect of retinoic acid and triiodothyronine on the age-related hypo-expression of neurogranin in rat. Neurobiol Aging 26(5): 729–738.
  37. 37. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3(7): 1–11.
  38. 38. Leclercq M, Bourgeay-Causse M (1981) Une méthode simple, fiable rapide: dosage simultané du rétinol et du tocophérol sérique par chromatographie liquide haute performance (A simple, reliable fast method: simultaneous proportioning of retinol and serum tocopherol by high performance liquid chromatography). Revue Institut Pasteur Lyon 14: 475–496.
  39. 39. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182(3): 311–322.
  40. 40. Rao MS, Shetty AK (2004) Efficacy of doublecortin as a marker to analyse the absolute number and dendritic growth of newly generated neurons in the adult dentate gyrus. Eur J Neurosci 19(2): 234–246.
  41. 41. Kempermann G, Gast D, Kronenberg G, Yamaguchi M, Gage FH (2003) Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development 130(2): 391–399.
  42. 42. Rodriguez-Tebar A, Rohrer H (1991) Retinoic acid induces NGF-dependent survival response and high-affinity NGF receptors in immature chick sympathetic neurons. Development 112(3): 813–820.
  43. 43. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ (1993) Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group. Neuron 11(2): 321–331.
  44. 44. Kobayashi M, Kurihara K, Matsuoka I (1994) Retinoic acid induces BDNF responsiveness of sympathetic neurons by alteration of Trk neurotrophin receptor expression. FEBS Lett 356(1): 60–65.
  45. 45. v Holst A, Lefcort F, Rohrer H (1997) TrkA expression levels of sympathetic neurons correlate with NGF-dependent survival during development and after treatment with retinoic acid. Eur J Neurosci 9(10): 2169–2177.
  46. 46. Xie P, Cheung WM, Ip FC, Ip NY, Leung MF (1997) Induction of TrkA receptor by retinoic acid in leukaemia cell lines. Neuroreport 8(5): 1067–1070.
  47. 47. Husson M, Enderlin V, Alfos S, Boucheron C, Pallet V, et al. (2004) Expression of neurogranin and neuromodulin is affected in the striatum of vitamin A-deprived rats. Brain Res Mol Brain Res 123(1–2): 7–17.
  48. 48. Kim YW, Sharma RP, Li JK (1994) Characterization of heterologously expressed recombinant retinoic acid receptors with natural or synthetic retinoids. J Biochem Toxicol 9(5): 225–234.
  49. 49. Krezel W, Kastner P, Chambon P (1999) Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 89(4): 1291–1300.
  50. 50. Zetterstrom RH, Lindqvist E, Mata de Urquiza A, Tomac A, Eriksson U, et al. (1999) Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci 11(2): 407–416.
  51. 51. Balmer JE, Blomhoff R (2002) Gene expression regulation by retinoic acid. J Lipid Res 43(11): 1773–1808.
  52. 52. Haskell GT, LaMantia AS (2005) Retinoic acid signaling identifies a distinct precursor population in the developing and adult forebrain. J Neurosci 25(33): 7636–7647.
  53. 53. Merlio JP, Ernfors P, Jaber M, Persson H (1992) Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience 51(3): 513–532.
  54. 54. Cellerino A (1996) Expression of messenger RNA coding for the nerve growth factor receptor trkA in the hippocampus of the adult rat. Neuroscience 70(3): 613–616.
  55. 55. Stancampiano R, Carta M, Fadda F (2007) Vitamin A deficiency affects neither frontocortical acetylcholine nor working memory. Neuroreport 18(3): 241–243.
  56. 56. Hellweg R, Humpel C, Lowe A, Hortnagl H (1997) Moderate lesion of the rat cholinergic septohippocampal pathway increases hippocampal nerve growth factor synthesis: evidence for long-term compensatory changes? Brain Res Mol Brain Res 45(1): 177–181.
  57. 57. Klein RL, Hirko AC, Meyers CA, Grimes JR, Muzyczka N, et al. (2000) NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats. Brain Res 875(1–2): 144–151.
  58. 58. Cooper-Kuhn CM, Winkler J, Kuhn HG (2004) Decreased neurogenesis after cholinergic forebrain lesion in the adult rat. J Neurosci Res 77(2): 155–165.
  59. 59. Mohapel P, Leanza G, Kokaia M, Lindvall O (2005) Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning. Neurobiol Aging 26(6): 939–946.
  60. 60. Frielingsdorf H, Simpson DR, Thal LJ, Pizzo DP (2007) Nerve growth factor promotes survival of new neurons in the adult hippocampus. Neurobiol Dis 26(1): 47–55.
  61. 61. Drager UC, McCaffery P (1997) Retinoic acid and the development of the retina. 16: 323–351.
  62. 62. Russell RM (2000) The vitamin A spectrum: from deficiency to toxicity. Am J Clin Nutr 71(4): 878–884.
  63. 63. Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, et al. (2006) Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats. Neuroscience 139(4): 1163–1172.
  64. 64. Ferguson SA, Berry KJ (2007) Oral Accutane (13-cis-retinoic acid) has no effects on spatial learning and memory in male and female Sprague-Dawley rats. Neurotoxicol Teratol 29(2): 219–227.
  65. 65. Dupret D, Revest JM, Koehl M, Ichas F, De giorgi F, Costet P, Abrous DN, Piazza PV (2008) Spatial relational memory requires hippocampal adult neurogenesis. PLoS One 3(4): e1959.
  66. 66. Bruel-Jungerman E, Davis S, Rampon C, Laroche S (2006) Long-term potentiation enhances neurogenesis in the adult dentate gyrus. J Neurosci 26(22): 5888–5893.
  67. 67. Krugers HJ, Van der Linden S, Van Olst E, Alfarez DN, Maslam S, Lucassen PJ, Joëls M (2007) Dissociation between apoptosis, neurogenesis, and synaptic potentiation in the dentate gyrus of adrenalectomized rats. Synapse (4): 221–30.
  68. 68. Boekhoorn K, Terwel D, Biemans B, Borghgraef P, Wiegert O, Ramakers GJ, de Vos K, Krugers H, Tomiyama T, Mori H, Joels M, van Leuven F, Lucassen PJ (2006) Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neurosci 26(13): 3514–23.
  69. 69. Drapeau E, Mayo W, Aurousseau C, Le Moal M, Piazza PV, et al. (2003) Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proc Natl Acad Sci U S A 100(24): 14385–14390.
  70. 70. Drapeau E, Montaron MF, Aguerre S, Abrous DN (2007) Learning-induced survival of new neurons depends on the cognitive status of aged rats. J Neurosci 27(22): 6037–6044.